Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to rise 188.44% to -25 cents per share on May 01

Autolus Therapeutics AUTL Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Beat

by $0.12

Q3'24

Missed

by $0.10

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.16

The last earnings report on March 20 showed earnings per share of -9 cents, beating the estimate of -20 cents. With 2.58M shares outstanding, the current market capitalization sits at 425.81M.

View a ticker or compare two or three

Compare

AUTL